ATE130196T1 - Menschliches mangansuperoxiddismutase und behandlungsverfahren. - Google Patents

Menschliches mangansuperoxiddismutase und behandlungsverfahren.

Info

Publication number
ATE130196T1
ATE130196T1 AT88104880T AT88104880T ATE130196T1 AT E130196 T1 ATE130196 T1 AT E130196T1 AT 88104880 T AT88104880 T AT 88104880T AT 88104880 T AT88104880 T AT 88104880T AT E130196 T1 ATE130196 T1 AT E130196T1
Authority
AT
Austria
Prior art keywords
superoxide dismutase
manganese superoxide
human manganese
treatment methods
terminus
Prior art date
Application number
AT88104880T
Other languages
English (en)
Inventor
Jacob R Hartman
Yaffa Beck
Abraham Nimrod
Original Assignee
Bio Technology General Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Technology General Corp filed Critical Bio Technology General Corp
Application granted granted Critical
Publication of ATE130196T1 publication Critical patent/ATE130196T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88104880T 1987-03-27 1988-03-25 Menschliches mangansuperoxiddismutase und behandlungsverfahren. ATE130196T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3273487A 1987-03-27 1987-03-27
US16111788A 1988-02-26 1988-02-26

Publications (1)

Publication Number Publication Date
ATE130196T1 true ATE130196T1 (de) 1995-12-15

Family

ID=26708809

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88104880T ATE130196T1 (de) 1987-03-27 1988-03-25 Menschliches mangansuperoxiddismutase und behandlungsverfahren.

Country Status (8)

Country Link
EP (2) EP0284105B1 (de)
JP (2) JP3013896B2 (de)
AT (1) ATE130196T1 (de)
CA (1) CA1339299C (de)
DE (1) DE3854678T2 (de)
GR (1) GR3018728T3 (de)
HK (1) HK210196A (de)
IL (1) IL85876A (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
DE3854872D1 (de) * 1987-03-14 1996-02-22 Boehringer Ingelheim Int Humane Mangan-Superoxiddismutase (hMn-SOD)
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
JPH0780784B2 (ja) * 1987-10-23 1995-08-30 宇部興産株式会社 微小循環障害に基づく心筋虚血傷害治療薬
JPH01233228A (ja) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd 悪性腫瘍細胞転移防止剤
US5200176A (en) * 1989-10-06 1993-04-06 Genentech, Inc. Method for protection of ischemic tissues using tumor nerosis factor
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
ATE209928T1 (de) * 1992-09-09 2001-12-15 Bio Technology General Corp Verwendung von mangan-superoxiddismutase (mn-sod) zur herstellung von arzneimitteln zur behandlung von erkrankungen in niedriger dosierung
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
AU5717094A (en) * 1992-12-28 1994-07-19 Sii Technoresearch, Inc. Human variant manganese superoxide dismutase
WO1994021283A1 (en) * 1993-03-24 1994-09-29 Boehringer Ingelheim Pharmaceuticals, Inc. Method for inhibiting pulmonary oxygen toxicity using manganese superoxide dismutase
US6887856B1 (en) * 1993-10-15 2005-05-03 University Of Pittsburgh Protection from ionizing irradiation or chemotherapeutic drug damage by in vivo gene therapy
US5985633A (en) * 1997-09-10 1999-11-16 University Of Florida Human manganese superoxide dismutase proteins
WO2001075175A2 (en) * 2000-03-31 2001-10-11 University Of Southern California Manganese superoxide dismutase gene polymorphism for predicting cancer susceptibility
CN101955918B (zh) * 2009-07-17 2014-05-21 华东理工大学 一种生产重组高活性锰超氧化物歧化酶的方法
ITRM20130608A1 (it) * 2013-11-04 2015-05-05 Aldo Mancini Manganese superossido dismutasi ricombinante e usi di essa
WO2015063306A1 (en) 2013-11-04 2015-05-07 Aldo Mancini Manganese superoxide dismutase variants and uses thereof
US10632089B2 (en) 2015-04-18 2020-04-28 Jo Cosmetics Co., Ltd. Tyrosinase activity inhibitor and external preparation for skin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5816685A (ja) * 1981-07-22 1983-01-31 Takeda Chem Ind Ltd 固定化酵素，その製造法および製剤
JPS5886098A (ja) * 1981-11-17 1983-05-23 Mamoru Sugiura マンガン−ス−パ−オキシドデイスムタ−ゼ測定用試薬
ATE155527T1 (de) * 1983-10-03 1997-08-15 Chiron Corp Superoxiddismutase und deren expression in mikroorganismen
CA1260858A (en) * 1985-03-28 1989-09-26 Lawrence S. Cousens Expression using fused genes providing for protein product
EP0213628A3 (de) * 1985-09-03 1988-09-21 Yeda Research And Development Company, Ltd. Expression von Superoxiddismutase in eukaryotischen Zellen
DK402785D0 (da) * 1985-09-03 1985-09-03 Syn Tek Ab Fremgangsmaade til fremstilling af et enzym
IE59498B1 (en) * 1985-11-22 1994-03-09 Bio Technology General Corp Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form
DE3854872D1 (de) * 1987-03-14 1996-02-22 Boehringer Ingelheim Int Humane Mangan-Superoxiddismutase (hMn-SOD)

Also Published As

Publication number Publication date
DE3854678T2 (de) 1996-06-13
JPS6427470A (en) 1989-01-30
EP0284105B1 (de) 1995-11-15
JP3013896B2 (ja) 2000-02-28
EP0691401A1 (de) 1996-01-10
JPH08317789A (ja) 1996-12-03
EP0284105A3 (en) 1989-01-25
DE3854678D1 (de) 1995-12-21
IL85876A0 (en) 1988-09-30
CA1339299C (en) 1997-08-19
IL85876A (en) 2001-11-25
GR3018728T3 (en) 1996-04-30
HK210196A (en) 1996-12-06
EP0284105A2 (de) 1988-09-28

Similar Documents

Publication Publication Date Title
ATE130196T1 (de) Menschliches mangansuperoxiddismutase und behandlungsverfahren.
EP0275005A3 (en) Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them
BG101028A (en) Synthetic peptide analogs of lung surfactant protein sp-c
GR3032207T3 (en) 2-Bromomelatonin in the therapy of sleep disorders
MY130145A (en) Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders.
DE69719798D1 (de) Periphäre verabreichung von glp-1 analogen und derivate zur reguleirung der fettleibigkeit
IL86633A (en) 2-furanone derivatives, their preparation and pharmaceutical compositions containing them
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
NZ258019A (en) Medicinal compositions containing potassium, zinc, calcium and rubidium ions having the same properties as oak bark extract
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
JPS57146800A (en) Aromatic heterocyclic esters of steroids, manufacture and pharmaceutical composition containing them
ATE61227T1 (de) Menschliche komplementfaktoren und ihre therapeutische verwendung.
IL108865A (en) Azabicyclic compounds their preparation and pharmaceutical compositions comprising them
IE40860B1 (en) Substituted benzamides
CA2158036A1 (en) 3,4-Diarylchromans for Treatment of Dermatitis
EP1032556A4 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
IL69475A (en) Polypeptide having an action on the immunological system,processes for its isolation and purification,its protease cleavage products and pharmaceutical compositions containing them
AU5323396A (en) Methods of treating inflammation and compositions therefor
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
UA27055C2 (uk) Лікарський препарат імуhозаміhhої дії hа осhові клітиhhої суспеhзії та спосіб лікуваhhя сиhдрому hабутого імуhодефіциту (віл-іhфекції) з використаhhям цього препарату
IL109076A0 (en) Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them
EP0333201A3 (en) Human heat shock factor
AU1400895A (en) 2,3-diaryl-1-benzopyrans for treating dermatitis
HUP0000812A2 (hu) Myelin bázikus fehérje peptid-fragmentumai az azokat tartalmazó gyógyszerkészítmények és felhasználásuk a sclerosis multiplex kezelésére

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee